Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
Ana Rita Pombo Antunes, Isabelle Scheyltjens, Francesca Lodi, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 4, pp. 595-610
Open Access | Times Cited: 447

Showing 26-50 of 447 citing articles:

Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 81
Differential plasticity and fate of brain-resident and recruited macrophages during the onset and resolution of neuroinflammation
Karen De Vlaminck, Hannah Van Hove, Daliya Kancheva, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 2085-2102.e9
Open Access | Times Cited: 77
Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma
Cristian Ruiz-Moreno, Sergio Marco Salas, Erik Samuelsson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 74
Characterizing cellular heterogeneity in chromatin state with scCUT&Tag-pro
Bingjie Zhang, Avi Srivastava, Eleni P. Mimitou, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 8, pp. 1220-1230
Open Access | Times Cited: 73
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
Yan Mei, Xiumei Wang, Ji Zhang, et al.
Nature Cancer (2023) Vol. 4, Iss. 9, pp. 1273-1291
Closed Access | Times Cited: 70
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma
Daniel S. Kirschenbaum, Kaikun Xie, Florian Ingelfinger, et al.
Cell (2023) Vol. 187, Iss. 1, pp. 149-165.e23
Closed Access | Times Cited: 69
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression
Ming Li, Hao Xu, Yanhua Qi, et al.
Oncogene (2022) Vol. 41, Iss. 41, pp. 4618-4632
Open Access | Times Cited: 64
Glioblastoma heterogeneity at single cell resolution
David Eisenbarth, Yanru Wang
Oncogene (2023) Vol. 42, Iss. 27, pp. 2155-2165
Open Access | Times Cited: 59
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1134-1151.e10
Open Access | Times Cited: 56
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma
Haofei Liu, Qiwen Zhao, Leyong Tan, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 693-710.e8
Open Access | Times Cited: 54
Brain macrophage development, diversity and dysregulation in health and disease
Aymeric Silvin, Jiawen Qian, Florent Ginhoux
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 11, pp. 1277-1289
Open Access | Times Cited: 50
TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
Rui Sun, Rowland H. Han, Colin McCornack, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 46
Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer
Stefan Naulaerts, Angeliki Datsi, Daniel Borràs, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Open Access | Times Cited: 41
Metabolic heterogeneity in cancer
Margherita Demicco, Xiao‐Zheng Liu, Katharina Leithner, et al.
Nature Metabolism (2024) Vol. 6, Iss. 1, pp. 18-38
Closed Access | Times Cited: 41
Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
Jiaxin Li, Jun Zhou, Huanhuan Huang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 39
Monocyte-neutrophil entanglement in glioblastoma
Dinorah Friedmann‐Morvinski, Dolores Hambardzumyan
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 38
Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
Zengpanpan Ye, Xiaolin Ai, Kailin Yang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 974-1001
Open Access | Times Cited: 37
Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
Philip Schmassmann, Julien Roux, Alicia Buck, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 705
Closed Access | Times Cited: 37
Multiomic spatial landscape of innate immune cells at human central nervous system borders
Roman Sankowski, Patrick Süß, Alexander Benkendorff, et al.
Nature Medicine (2023) Vol. 30, Iss. 1, pp. 186-198
Open Access | Times Cited: 37
Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy
Jing Kuang, Zhi‐Yong Rao, Di‐Wei Zheng, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13333-13347
Closed Access | Times Cited: 36
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner
Gregory P. Takacs, Christian J. Kreiger, Defang Luo, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 35
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 33
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1105-1123.e8
Closed Access | Times Cited: 30
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
Wenying Wang, Tianran Li, Yue Cheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 815-832.e12
Open Access | Times Cited: 25

Scroll to top